5-13931231-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001369.3(DNAH5):​c.71G>A​(p.Gly24Glu) variant causes a missense change. The variant allele was found at a frequency of 0.324 in 1,613,668 control chromosomes in the GnomAD database, including 92,045 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 13455 hom., cov: 33)
Exomes 𝑓: 0.32 ( 78590 hom. )

Consequence

DNAH5
NM_001369.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 5.59
Variant links:
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.3286577E-6).
BP6
Variant 5-13931231-C-T is Benign according to our data. Variant chr5-13931231-C-T is described in ClinVar as [Benign]. Clinvar id is 163159.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-13931231-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.679 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
DNAH5NM_001369.3 linkuse as main transcriptc.71G>A p.Gly24Glu missense_variant 2/79 ENST00000265104.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
DNAH5ENST00000265104.5 linkuse as main transcriptc.71G>A p.Gly24Glu missense_variant 2/791 NM_001369.3 P4

Frequencies

GnomAD3 genomes
AF:
0.399
AC:
60659
AN:
151986
Hom.:
13436
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.571
Gnomad AMI
AF:
0.274
Gnomad AMR
AF:
0.392
Gnomad ASJ
AF:
0.346
Gnomad EAS
AF:
0.698
Gnomad SAS
AF:
0.375
Gnomad FIN
AF:
0.284
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.297
Gnomad OTH
AF:
0.396
GnomAD3 exomes
AF:
0.367
AC:
92279
AN:
251192
Hom.:
18898
AF XY:
0.358
AC XY:
48582
AN XY:
135742
show subpopulations
Gnomad AFR exome
AF:
0.576
Gnomad AMR exome
AF:
0.421
Gnomad ASJ exome
AF:
0.332
Gnomad EAS exome
AF:
0.695
Gnomad SAS exome
AF:
0.360
Gnomad FIN exome
AF:
0.271
Gnomad NFE exome
AF:
0.293
Gnomad OTH exome
AF:
0.336
GnomAD4 exome
AF:
0.316
AC:
462539
AN:
1461564
Hom.:
78590
Cov.:
40
AF XY:
0.316
AC XY:
229815
AN XY:
727088
show subpopulations
Gnomad4 AFR exome
AF:
0.580
Gnomad4 AMR exome
AF:
0.423
Gnomad4 ASJ exome
AF:
0.337
Gnomad4 EAS exome
AF:
0.694
Gnomad4 SAS exome
AF:
0.357
Gnomad4 FIN exome
AF:
0.276
Gnomad4 NFE exome
AF:
0.288
Gnomad4 OTH exome
AF:
0.334
GnomAD4 genome
AF:
0.399
AC:
60722
AN:
152104
Hom.:
13455
Cov.:
33
AF XY:
0.398
AC XY:
29605
AN XY:
74350
show subpopulations
Gnomad4 AFR
AF:
0.571
Gnomad4 AMR
AF:
0.393
Gnomad4 ASJ
AF:
0.346
Gnomad4 EAS
AF:
0.698
Gnomad4 SAS
AF:
0.374
Gnomad4 FIN
AF:
0.284
Gnomad4 NFE
AF:
0.297
Gnomad4 OTH
AF:
0.395
Alfa
AF:
0.318
Hom.:
19761
Bravo
AF:
0.415
TwinsUK
AF:
0.285
AC:
1056
ALSPAC
AF:
0.282
AC:
1085
ESP6500AA
AF:
0.563
AC:
2480
ESP6500EA
AF:
0.302
AC:
2599
ExAC
AF:
0.369
AC:
44816
Asia WGS
AF:
0.508
AC:
1764
AN:
3476
EpiCase
AF:
0.283
EpiControl
AF:
0.287

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 21, 2013Gly24Glu in exon 2 of DNAH5: This variant is not expected to have clinical signi ficance because it has been identified in 43.7% (1926/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs1530496). -
Primary ciliary dyskinesia Benign:3
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 01, 2014This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Primary ciliary dyskinesia 3 Benign:3
Benign, criteria provided, single submitterclinical testingPars Genome LabJun 15, 2021- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 30, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxNov 10, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
21
DANN
Benign
0.50
DEOGEN2
Benign
0.019
T
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.45
FATHMM_MKL
Benign
0.011
N
LIST_S2
Benign
0.33
T
MetaRNN
Benign
0.0000043
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-3.0
N
MutationTaster
Benign
1.0
P
PrimateAI
Benign
0.47
T
PROVEAN
Benign
4.0
N
REVEL
Benign
0.15
Sift
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.037
MPC
0.12
ClinPred
0.0094
T
GERP RS
5.6
Varity_R
0.14
gMVP
0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1530496; hg19: chr5-13931340; COSMIC: COSV54209173; API